A detailed history of High Tower Advisors, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 154,261 shares of ACCD stock, worth $570,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154,261
Previous 154,261 -0.0%
Holding current value
$570,765
Previous $552,000 7.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.58 - $10.13 $552,254 - $1.56 Million
154,261 New
154,261 $552,000
Q4 2023

Feb 12, 2024

SELL
$6.5 - $12.85 $128,303 - $253,646
-19,739 Reduced 8.87%
202,788 $2.44 Million
Q3 2023

Nov 08, 2023

BUY
$10.45 - $15.02 $2.33 Million - $3.34 Million
222,527 New
222,527 $2.35 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $266M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.